产品标题 产品货号 产品规格 厂家
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS6304345x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS6315895x5umORIGENE TECHNOLOGIES
Human Breast; Adenocarcinoma of breast, ductal from ORIGENE TECHNOLOGIESCS6317205x5umORIGENE TECHNOLOGIES
Cysteine-rich with EGF-like domains 1 (CRELD1), transcript variant 1 from ORIGENE TECHNOLOGIESLY422168100 ugORIGENE TECHNOLOGIES
Cysteine-rich with EGF-like domains 1 (CRELD1), transcript variant 2 from ORIGENE TECHNOLOGIESLY414506100 ugORIGENE TECHNOLOGIES
Cysteine-rich with EGF-like domains 1 (CRELD1), transcript variant 3 from ORIGENE TECHNOLOGIESLY425847100 ugORIGENE TECHNOLOGIES
Cysteine-rich with EGF-like domains 1 (CRELD1), transcript variant 3 from ORIGENE TECHNOLOGIESLY421411100 ugORIGENE TECHNOLOGIES
Cysteine-rich with EGF-like domains 2 (CRELD2), transcript variant 1 from ORIGENE TECHNOLOGIESLY427551100 ugORIGENE TECHNOLOGIES
Cysteine-serine-rich nuclear protein 1 (CSRNP1) from ORIGENE TECHNOLOGIESLY409787100 ugORIGENE TECHNOLOGIES
Cysteine-serine-rich nuclear protein 2 (CSRNP2) from ORIGENE TECHNOLOGIESLY410704100 ugORIGENE TECHNOLOGIES
Cysteine-serine-rich nuclear protein 3 (CSRNP3), transcript variant 1 from ORIGENE TECHNOLOGIESLY433313100 ugORIGENE TECHNOLOGIES
Cysteine-serine-rich nuclear protein 3 (CSRNP3), transcript variant 2 from ORIGENE TECHNOLOGIESLY403042100 ugORIGENE TECHNOLOGIES
Cysteine sulfinic acid decarboxylase (CSAD) from ORIGENE TECHNOLOGIESLY432285100 ugORIGENE TECHNOLOGIES
Cysteine-rich with EGF-like domains 2 (CRELD2), transcript variant 2 from ORIGENE TECHNOLOGIESLY411304100 ugORIGENE TECHNOLOGIES
Cysteine sulfinic acid decarboxylase (CSAD) from ORIGENE TECHNOLOGIESLY402481100 ugORIGENE TECHNOLOGIES
Cysteine/tyrosine-rich 1 (CYYR1) from ORIGENE TECHNOLOGIESLY403280100 ugORIGENE TECHNOLOGIES
Cysteinyl leukotriene receptor 2 (CYSLTR2) from ORIGENE TECHNOLOGIESLY412509100 ugORIGENE TECHNOLOGIES
Cysteinyl-tRNA synthetase (CARS), transcript variant 1 from ORIGENE TECHNOLOGIESLY408331100 ugORIGENE TECHNOLOGIES
Cysteinyl leukotriene receptor 1 (CYSLTR1) from ORIGENE TECHNOLOGIESLY416513100 ugORIGENE TECHNOLOGIES
Cysteinyl-tRNA synthetase (CARS), transcript variant 3 from ORIGENE TECHNOLOGIESLY423062100 ugORIGENE TECHNOLOGIES
Cystin 1 (CYS1) from ORIGENE TECHNOLOGIESLY422152100 ugORIGENE TECHNOLOGIES
Cystinosis, nephropathic (CTNS), transcript variant 2 from ORIGENE TECHNOLOGIESLY417639100 ugORIGENE TECHNOLOGIES
Cystinosis, nephropathic (CTNS), transcript variant 1 from ORIGENE TECHNOLOGIESLY421897100 ugORIGENE TECHNOLOGIES
Cystinosis, nephropathic (CTNS), transcript variant 2 from ORIGENE TECHNOLOGIESLY429231100 ugORIGENE TECHNOLOGIES
CYSTM1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4048131 kitORIGENE TECHNOLOGIES
CYTH3 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4060031 kitORIGENE TECHNOLOGIES
CYTH2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4071791 kitORIGENE TECHNOLOGIES
Cystm1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042021 kitORIGENE TECHNOLOGIES
CYTH4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4080431 kitORIGENE TECHNOLOGIES
CYTH1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4168081 kitORIGENE TECHNOLOGIES
Cyth1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042031 kitORIGENE TECHNOLOGIES
Cyth2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042041 kitORIGENE TECHNOLOGIES
Cyth3 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042051 kitORIGENE TECHNOLOGIES
Cyth4 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042061 kitORIGENE TECHNOLOGIES
CYTH1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31680810 ugORIGENE TECHNOLOGIES
CYTH2 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH31798010 ugORIGENE TECHNOLOGIES
CYTH3 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30600310 ugORIGENE TECHNOLOGIES
CYTH4 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30804310 ugORIGENE TECHNOLOGIES
Cytidine and dCMP deaminase domain containing 1 (CDADC1) from ORIGENE TECHNOLOGIESLY410668100 ugORIGENE TECHNOLOGIES
Cytidine and dCMP deaminase domain containing 1 (CDADC1), transcript variant 2 from ORIGENE TECHNOLOGIESLY434270100 ugORIGENE TECHNOLOGIES
Cytidine deaminase (CDA) from ORIGENE TECHNOLOGIESLY419748100 ugORIGENE TECHNOLOGIES
Cytidine monophosphate N-acetylneuraminic acid synthetase (CMAS) from ORIGENE TECHNOLOGIESLY402711100 ugORIGENE TECHNOLOGIES
Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (CMPK1), transcript variant 1 from ORIGENE TECHNOLOGIESLY402539100 ugORIGENE TECHNOLOGIES
Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic (CMPK1), transcript variant 2 from ORIGENE TECHNOLOGIESLY427824100 ugORIGENE TECHNOLOGIES
Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial (CMPK2), nuclear gene encoding mitochondrial protein from ORIGENE TECHNOLOGIESLY404093100 ugORIGENE TECHNOLOGIES
CYTIP - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4060021 kitORIGENE TECHNOLOGIES
Cytip - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042071 kitORIGENE TECHNOLOGIES
CYTL1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN4067781 kitORIGENE TECHNOLOGIES
Cytl1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIESKN5042081 kitORIGENE TECHNOLOGIES
CYTL1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIESPH30677810 ugORIGENE TECHNOLOGIES
 |< < 3619 3620 3621 3622 3623 3624 3625 3626 3627 > >| 第 3623/6274 页